Trial intelligence / Profile preview

Magnesium Therapy for Post-operative Atrial Fibrillation

NCT02928315Completed

Sponsor
Assiut University
Start
Aug 2015
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of magnesium sulfate in Atrial fibrillation (AFib) (2 arms), sponsored by Assiut University. Primary endpoint: Atrial fibrillation at 3 days. Started Aug 2015; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT02928315.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02928315.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call